Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial.

被引：0
|
作者：
Budde, K. [1 ]
Morales, J. [2 ]
Blancho, G. [3 ]
Muehlbacher, F. [4 ]
Lehner, F. [5 ]
Rice, K. [6 ]
Pupim, L.
Aigner, S.
Vincenti, F. [7 ]
机构：
[1] Charite, Berlin, Germany
[2] Hosp 12 Octubre Madrid, Madrid, Spain
[3] Univ Hosp Nantes, Nantes, France
[4] Med Univ Vienna, Vienna, Austria
[5] Hannover Med Sch, Hannover, Germany
[6] Baylor Univ, Med Ctr, Waco, TX 76798 USA
[7] Univ Calif San Francisco, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：182 / 183
页数：2
相关论文
共 38 条
  • [1] Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
    Pestana, J. O. M.
    Grinyo, J. M.
    Vanrenterghem, Y.
    Becker, T.
    Campistol, J. M.
    Florman, S.
    Garcia, V. D.
    Kamar, N.
    Lang, P.
    Manfro, R. C.
    Massari, P.
    Rial, M. D. C.
    Schnitzler, M. A.
    Vitko, S.
    Duan, T.
    Block, A.
    Harler, M. B.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 630 - 639
  • [2] Belatacept Compared with Cyclosporine in Renal Allograft Recipients of Extended Criteria Donor Kidneys: 3-Year Outcomes from the Phase III BENEFIT-EXT Trial.
    Medina Pestana, J.
    Grinyo, J.
    Vanrenterghem, Y.
    Becker, T.
    Florman, S.
    Lang, P.
    Rial, M. del C.
    Schnitzler, M.
    Duan, T.
    Block, A.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 349 - 349
  • [3] DONOR SUB-TYPE ANALYSIS OF THREE-YEAR OUTCOMES FROM A PHASE III STUDY OF BELATACEPT IN RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS (BENEFIT-EXT TRIAL)
    Muehlbacher, Ferdinand
    Becker, Thomas
    Campistol, Josep M.
    Carvalho, Deise B. M.
    Florman, Sander
    Lang, Philippe
    Duan, Tao
    Agarwal, Mamta
    Larsen, Christian P.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 221 - 222
  • [4] BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL
    Medina Pestana, Jose O.
    Grinyo, Josep M.
    Vanrenterghem, Yves
    Becker, Thomas
    Florman, Sander
    Lang, Philippe
    Rial, Maria del C.
    Schnitzler, Mark A.
    Duan, Tao
    Block, Alan
    Durrbachll, Antoine
    TRANSPLANT INTERNATIONAL, 2011, 24 : 68 - 68
  • [5] BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL
    Medina Pestana, J.
    Grinyo, J.
    Vanrenterghem, Y.
    Becker, T.
    Florman, S.
    Lang, P.
    Rial, M. del C.
    Schnitzler, M.
    Duan, T.
    Block, A.
    Durrbach, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 51 - 51
  • [6] Three-Year Outcomes by Donor Type in Phase III Studies of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT & BENEFIT-EXT)
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    DeCarvalho, D.
    Muehlbacher, F.
    O'Connell, P.
    Duan, T.
    Agarwal, M.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 100 - 100
  • [7] IMPACT OF DONOR AGE ON 3-YEAR OUTCOMES OF EXTENDED CRITERIA DONOR KIDNEY RECIPIENTS IN BENEFIT-EXT
    Lehner, Frank
    Budde, Klemens M. D.
    Morales, Jose M.
    Blancho, Gilles
    Muehlbacher, Ferdinand
    Rice, Kim
    Pupim, Lara
    Aigner, Sigrid
    Vincenti, Flavio
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
  • [8] BENEFIT-EXT STUDY TWO YEAR OUTCOMES: BELATACEPT VS CYCLOSPORINE (CSA) IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANTS
    Russ, G.
    Durrbach, A.
    Larsen, C. P.
    Pestana, Medina J.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Christina, Xinos
    Grinyo, J.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A2 - A2
  • [9] Three-Year Outcomes in Elderly Kidney Transplant Recipients Treated with Belatacept vs Cyclosporine in BENEFIT-EXT.
    Rice, K.
    Vanrenterghem, Y.
    Merville, P.
    Muehlbacher, F.
    Zhang, R.
    Duan, T.
    Thomas, D.
    Charpentier, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 403 - 403
  • [10] THREE YEAR OUTCOMES BY DONOR TYPE IN PHASE III STUDIES OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT AND BENEFIT-EXT)
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    Carvalho, D.
    Muehlbacher, F.
    O'Connell, P.
    Duan, T.
    Agarwal, M.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 51 - 51
1234